Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Benz

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|August 5, 1991
p185HER2 signal transduction in breast cancer cellsG K Scott, J M Dodson, P A Montgomery, et al.
Gene Therapy|December 13, 2005
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene deliveryM E Hayes, D C Drummond, D B Kirpotin, et al.
Molecular Pharmacology|June 1, 1990
Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomersC C Benz, M A Keniry, J M Ford, et al.
Oncogene|April 3, 1997
ESX: a structurally unique Ets overexpressed early during human breast tumorigenesisC H Chang, G K Scott, W L Kuo, et al.
Oncogene|October 31, 1997
HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancerC C Benz, R C O'Hagan, B Richter, et al.
Molecular Pharmaceutics|December 5, 2006
Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylationM E Hayes, D C Drummond, K Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancerJ Baselga, D Tripathy, J Mendelsohn, et al.
Seminars in Oncology|September 11, 1999
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancerJ Baselga, D Tripathy, J Mendelsohn, et al.
Breast Cancer Research and Treatment|January 24, 2002
Expedition inspiration consensus 2001C C Benz, L Hilakivi-Clarke, S Conzen, et al.
Endocrine-Related Cancer|August 23, 2005
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatmentJ M W Gee, A Howell, W J Gullick, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|August 5, 1991
p185HER2 signal transduction in breast cancer cellsG K Scott, J M Dodson, P A Montgomery, et al.
Gene Therapy|December 13, 2005
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene deliveryM E Hayes, D C Drummond, D B Kirpotin, et al.
Molecular Pharmacology|June 1, 1990
Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomersC C Benz, M A Keniry, J M Ford, et al.
Oncogene|April 3, 1997
ESX: a structurally unique Ets overexpressed early during human breast tumorigenesisC H Chang, G K Scott, W L Kuo, et al.
Oncogene|October 31, 1997
HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancerC C Benz, R C O'Hagan, B Richter, et al.
Molecular Pharmaceutics|December 5, 2006
Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylationM E Hayes, D C Drummond, K Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancerJ Baselga, D Tripathy, J Mendelsohn, et al.
Seminars in Oncology|September 11, 1999
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancerJ Baselga, D Tripathy, J Mendelsohn, et al.
Breast Cancer Research and Treatment|January 24, 2002
Expedition inspiration consensus 2001C C Benz, L Hilakivi-Clarke, S Conzen, et al.
Endocrine-Related Cancer|August 23, 2005
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatmentJ M W Gee, A Howell, W J Gullick, et al.
Pageof 8